Related Experiment Video
Updated: Jul 4, 2026
10:36
In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues
Published on: March 21, 2017
Development of a thyroid hormone receptor targeting conjugate
Jianfei Zheng1, Atsushi Hashimoto, Marc Putnam
1Department of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, USA.
Bioconjugate Chemistry
|May 30, 2008
Summary
Researchers developed novel molecular conjugates targeting the thyroid hormone receptor beta (TRbeta). One conjugate, JZ01, acts as a non-radioactive probe for TRbeta binding, while JZ07 functions as a selective TR antagonist.
Area of Science:
- Chemical Biology
- Molecular Endocrinology
- Medicinal Chemistry
Background:
- Molecular conjugates are valuable tools in chemical biology, but practical conjugates targeting the nuclear thyroid hormone receptor beta (TRbeta) are scarce.
- Existing hormone conjugates primarily target steroid hormone receptors, leaving a gap in TRbeta-targeted molecular probes and therapeutics.
Purpose of the Study:
- To synthesize and evaluate novel TRbeta-targeting conjugate scaffolds based on known TR ligands.
- To identify functional TRbeta-targeting molecular probes and antagonists for research applications.
Main Methods:
- Synthesis of TR-targeting conjugate scaffolds using ligands GC-1, NH-2, and triiodothyronine (T3).
- In vitro and cellular assays to evaluate ligand binding affinity, selectivity, and cellular localization.
- Characterization of conjugate interactions with TRbeta and TRalpha.
Main Results:
- TRbeta-targeting conjugates based on T3 and GC-1 exhibited low binding affinity.
- An NH-2-inspired fluorescein conjugate, JZ01, demonstrated low nanomolar affinity for TRbeta and served as a non-radiometric ligand-binding probe.
- A related analogue, JZ07, proved to be a potent TR antagonist with 13-fold selectivity for TRbeta over TRalpha, and JZ01 localized to the nuclei of TRbeta-expressing cells.
Conclusions:
- The developed NH-2-inspired conjugate JZ01 is a promising non-radiometric probe for TRbeta ligand binding studies.
- JZ07 represents a potent and selective TRbeta antagonist, potentially useful for therapeutic development.
- These TR-targeting conjugates serve as prototypes for developing advanced molecular tools in thyroid hormone receptor research.
More Related Videos
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:08Intracellular Hormone Receptors
Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
01:18Functions of Thyroid Hormones
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...